News

Aperio Technologies has received clearance from the FDA to market the IHC HER2 Breast Tissue Tunable Image Analysis application, available through its patented digital pathology platform. The application

Synexus has acquired three more clinical trial centres in Poland. Dr. Andrzej Opadczuk will continue to manage the centres and will report to Dr. Christian Tueni, vice president,

NovaDel has received a milestone payment of approximately $150,000 from Velcera relating to its License and Development Agreement with the latter. The agreement provides Velcera with a license

Warner Chilcott has proposed to acquire Procter & Gamble’s prescription-drug business. Warner Chilcott is likely to pay $3 billion for the business unit. Wall Street Journal has reported

Valeant has reported preliminary results from its phase IIa proof-of-concept clinical trial of retigabine, for the treatment of pain associated with postherpetic neuralgia (PHN). Reportedly, retigabine was generally

UCB and Novartis have entered into a licensing agreement for cardiovascular and diabetes products in Germany. Under the agreement, UCB has extended commercial rights for the German market

Ranbaxy Laboratories has received approval from the US Food and Drug Administration (FDA) to manufacture and market Glycopyrrolate Tablets USP, 1mg and 2mg. The Ranbaxy formulations is bioequivalent

The FDA is reviewing adverse event reports of liver injury in patients taking the weight loss drug orlistat, marketed as the prescription drug, Xenical and the over-the-counter medication,

Bavarian Nordic has announced that the US authorities have initiated negotiations for a new contract to develop a freeze-dried version of the IMVAMUNE smallpox vaccine. The company said